Market Place
Sourcing Support
Biogen Sued Over Alleged PBM Kickbacks For Tecfidera
21 Aug 2024 //
FIERCE PHARMA
Macleods Pharms Generic Dimethyl Fumarate Receives Approval in US
26 Jun 2024 //
FDA
EC revokes all centrally granted generic marketing permissions for DMF
20 Dec 2023 //
PR NEWSWIRE
Biogen notches another Tecfidera patent win in Europe
20 Dec 2023 //
FIERCE PHARMA
Biogen finally scores win in its fight to prevent copycats of MS drug in the EU
04 May 2023 //
ENDPTS
Biogen Receives Favorable Decision from Court of the EU Relating to TECFIDERA
17 Mar 2023 //
PRESS RELEASE
Aurobindo`s Generic Dimethyl Fumarate Receives Approval in the U.S.
22 Dec 2022 //
FDA
Stem cell transplants may slow disability progression in MS
22 Dec 2022 //
EUROPEANPHARMACEUTICALREVIEW
Prinston`s Generic Dimethyl Fumarate Receives Approval in the U.S.
18 Oct 2022 //
FDA
Biogen`s push to regain Tecfidera patent swatted down by SCOTUS
03 Oct 2022 //
FIERCEPHARMA
Biogen pays $900M to resolve whistleblower`s kickbacks suit
21 Jul 2022 //
FIERCEPHARMA
Biogen has gained a prominent ally in its Tecfidera patent suit
14 Jul 2022 //
FIERCEPHARMA
European Patent Office Grants Patent Related to TECFIDERA (Dimethyl Fumarate)
21 Jun 2022 //
GLOBENEWSWIRE
Polpharma Generic Dimethyl fumarate Receives Approval in Europe
17 Jun 2022 //
EMA
Neuraxpharm Generic Dimethyl fumarate Receives Approval in Europe
13 Jun 2022 //
EMA
Mylan Ireland Generic Dimethyl fumarate Receives Approval in Europe
25 May 2022 //
EMA
Biogen`s Tecfidera patent contingency plan falls flat amid sputtering Aduhelm
18 Mar 2022 //
FIERCE PHARMA
New MAVENCLAD Data at ACTRIMS Forum 2022 Show Favourable Efficacy Outcomes
24 Feb 2022 //
BUSINESSWIRE
Viatris Wins Federal Circuit Court Appeal Invalidating Biogen`s Tecfidera Patent
01 Dec 2021 //
PRNEWSWIRE
China NMPA approves Biogen’s Tecfidera to treat multiple sclerosis
19 Apr 2021 //
PHARMABIZ
BIOGEN GROWS PRESENCE IN CHINA WITH THE APPROVAL OF TECFIDERA®
16 Apr 2021 //
PRESS RELEASE
Pharmathen `s Generic Dimethyl Fumarate Receives Approval In US
31 Mar 2021 //
FDA
Biogen is running out of safety nets
21 Oct 2020 //
BIOPHARMADIVE
Abarca Details First Value-Based Agreement For Medicaid Members Biogen
20 Oct 2020 //
PRNEWSWIRE
Lupin Atlantis`s Generic Dimethyl Fumarate Receives Approval In US
08 Oct 2020 //
FDA
Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate
07 Oct 2020 //
BLOOMBERG
Glenmark Pharma share price rises on final USFDA approval for a generic
06 Oct 2020 //
MONEY CONTROL
Lupin receives US FDA approval to market generic Tecfidera DR capsules
05 Oct 2020 //
PHARMABIZ
Dr Reddys Labs launches Tecfidera generic in US market
28 Sep 2020 //
BUSINESS STANDARD
Cipla receives final approval for Dimethyl Fumarate DR Capsules
25 Sep 2020 //
PRESS RELEASE
Dr Reddy`s launches generic drug to treat multiple sclerosis in US
25 Sep 2020 //
ECONOMICTIMES
Zydus Pharms`s Generic Dimethyl Fumarate Receives Approval In US
24 Sep 2020 //
FDA
Hetero Labs Ltd III`s Generic Dimethyl Fumarate Receives Approval In US
24 Sep 2020 //
FDA
Accord Hlthcare`s Generic Dimethyl Fumarate Receives Approval In US
24 Sep 2020 //
FDA
MSN`s Generic Dimethyl Fumarate Receives Approval In US
24 Sep 2020 //
FDA
Alkem Labs`s Generic Dimethyl Fumarate Receives Approval In US
24 Sep 2020 //
FDA
Amneal`s Generic Dimethyl Fumarate Receives Approval In US
24 Sep 2020 //
FDA
Cipla`s Generic Dimethyl Fumarate Receives Approval In US
24 Sep 2020 //
FDA
Cipla surges 5% on USFDA approval for dimethyl fumarate DR capsules
24 Sep 2020 //
BUSINESS STANDARD
Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drug
24 Sep 2020 //
ECONOMICTIMES
Roche`s Ocrevus touts 2-year switching data in multiple sclerosis market
11 Sep 2020 //
FIERCE PHARMA
Mylan Pharms`s Dimethyl Fumarate Receives Approval in US
20 Aug 2020 //
FDA
Mylan launches copy of Biogen`s top drug despite ongoing court battle
20 Aug 2020 //
BIOPHARMADIVE
Mylan wins an early FDA OK for a Tecfidera knockoff, with Biogen’s blockbuster
18 Aug 2020 //
ENDPTS
Biogen`s last-ditch pitch for an injunction to protect Tecfidera is denied Mylan
30 Jul 2020 //
ENDPTS
Enforcement Report - Week of July 15
16 Jul 2020 //
FDA
Mylan, looking to capitalize on Biogen`s Tecfidera patent loss
23 Jun 2020 //
FIERCE PHARMA
Biogen might just lose its key Tecfidera patent fight: analyst
11 Jun 2020 //
FIERCE PHARMA
MSN Lab`s Generic Dimethyl Fumarate Receives Tentative Approval In US
10 Jun 2020 //
FDA
Biogen shares soar 32% on MS drug patent win over Mylan
07 Feb 2020 //
REUTERS
Biogen wins Tecfidera patent challenge from Mylan; shares jump
06 Feb 2020 //
FIERCE PHARMA
Biogen Investors Face Next Test With Pending Drug Patent Ruling
04 Feb 2020 //
BLOOMBERG
Biogen’s Tecfidera holds its own in MS as competition looms
31 Jan 2020 //
FIERCE PHARMA
Amarin can pull off Vascepa expansion without major partner: CEO
01 Aug 2019 //
FIERCE PHARMA
The patent play: Biogen gets a PhIII boost for bit-better take on blockbuster
31 Jul 2019 //
ENDPTS
Who`s the next Big Pharma takeout target? Biogen, uniQure, AZ top the list
26 Jun 2019 //
FIERCE PHARMA
Troubled Biogen shows off its me-better approach to MS on PhIII update
31 May 2019 //
ENDPTS
Biogen trumpets safety data for Tecfidera follow-up
30 May 2019 //
PMLIVE
Stung by aducanumab flop, Biogen execs confront their fears
25 Apr 2019 //
FIERCE PHARMA
Biogen investors have plenty to worry about, $5B buyback or no
27 Mar 2019 //
FIERCE PHARMA
